Valuation: H&R GmbH & Co. KGaA

Market Cap 255M 281M 235M 212M 400M 26.49B 415M 2.83B 1.12B 14.15B 1.05B 1.03B 44.92B P/E 2026 *
4.55x
P/E 2027 * 11.2x
Enterprise Value 272M 300M 252M 227M 428M 28.31B 443M 3.02B 1.2B 15.12B 1.13B 1.1B 48B EV / Sales 2026 *
0.19x
EV / Sales 2027 * 0.18x
Free-Float
21.97%
Yield 2026 *
2.19%
Yield 2027 * 1.46%
11-13 H&R GmbH & Co. KGaA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 CI
08-15 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-15 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-01 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2025 CI
01-28 Kepler Cheuvreux Favors BASF and Bayer, Avoids H&R and Evonik DP
11-15 H&R GmbH & Co. KGaA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
11-14 H&R GmbH & Co. KGaA Revises Earnings Guidance for the Full Year 2025 CI
25/08/25 Nils Hansen acquired additional 7.78% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?15 million. CI
15/08/25 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
16/05/25 Nils Hansen proposed to acquire remaining 38.55% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?73 million. CI
14/05/25 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
17/04/25 H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 CI
09/04/25 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
1 day-1.16%
1 week+0.59%
Current month-2.84%
1 month-3.66%
3 months+11.04%
6 months+45.53%
Current year+59.44%
1 week 6.7
Extreme 6.7
7.08
1 month 6.38
Extreme 6.38
7.26
Current year 3.91
Extreme 3.91
7.6
1 year 3.91
Extreme 3.91
7.6
3 years 3.23
Extreme 3.23
7.6
5 years 3.23
Extreme 3.23
8.38
10 years 3.23
Extreme 3.23
16.15
Manager TitleAgeSince
Chief Executive Officer 61 01/01/2016
Investor Relations Contact - 01/01/2006
Director TitleAgeSince
Chairman 62 17/04/2012
Director/Board Member 71 01/05/2011
Director/Board Member 69 01/05/2011
Change 5-day change 1-year change 3-year change Capi.($)
-1.16%+0.59%+39.02%+41.32% 281M
+0.68%+2.10%+24.25%+30.29% 242B
+0.25%+2.95%+24.30%+38.41% 136B
-0.20%+1.68%+5.33%+31.37% 84.03B
+3.75%+26.93%+446.76%+362.01% 73.25B
+0.10%+3.83%+22.05%+17.93% 70.49B
-1.11%+1.14%-14.97%-40.91% 38.84B
-1.20%-6.28%+3.48%-17.65% 31.93B
+0.17%+0.15%+26.31%-8.20% 27.07B
+0.53%+0.16%-12.26%-17.36% 25.94B
Average +0.18%+2.24%+56.43%+43.72% 73B
Weighted average by Cap. +0.55%+3.19%+60.09%+55.04%

Financials

2026 *2027 *
Net sales 1.47B 1.62B 1.36B 1.23B 2.31B 153B 2.39B 16.33B 6.48B 81.69B 6.09B 5.96B 259B 1.42B 1.56B 1.31B 1.18B 2.23B 147B 2.31B 15.73B 6.24B 78.69B 5.86B 5.74B 250B
Net income 49.3M 54.4M 45.6M 41.14M 77.53M 5.13B 80.27M 548M 217M 2.74B 204M 200M 8.7B 23.6M 26.04M 21.83M 19.69M 37.12M 2.46B 38.42M 262M 104M 1.31B 97.73M 95.66M 4.16B
Net Debt 17.48M 19.29M 16.17M 14.59M 27.49M 1.82B 28.46M 194M 77.02M 972M 72.39M 70.86M 3.08B -5.88M -6.49M -5.44M -4.91M -9.25M -612M -9.58M -65.35M -25.91M -327M -24.36M -23.84M -1.04B
Projected Income Statement - Annual - H&R GmbH & Co. KGaA
Logo H&R GmbH & Co. KGaA
H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
Employees
1,688
Date Price Change Volume
13/11/26 €6.840 -1.16% 2,106
12/11/26 €6.920 +2.67% 15,824
11/11/26 €6.740 -0.30% 1
10/11/26 €6.760 -0.59% 4,315
09/11/26 €6.800 0.00% 2,188
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - H&R GmbH & Co. KGaA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.840EUR
Average target price
8.200EUR
Spread / Average Target
+19.88%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - H&R GmbH & Co. KGaA
  1. Stock Market
  2. Stocks
  3. 2HRA Stock